Richard C. Becker

1.1k total citations
35 papers, 681 citations indexed

About

Richard C. Becker is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Richard C. Becker has authored 35 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 10 papers in Internal Medicine and 9 papers in Hematology. Recurrent topics in Richard C. Becker's work include Antiplatelet Therapy and Cardiovascular Diseases (29 papers), Acute Myocardial Infarction Research (12 papers) and Venous Thromboembolism Diagnosis and Management (10 papers). Richard C. Becker is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (29 papers), Acute Myocardial Infarction Research (12 papers) and Venous Thromboembolism Diagnosis and Management (10 papers). Richard C. Becker collaborates with scholars based in United States, United Kingdom and Australia. Richard C. Becker's co-authors include Jason N. Katz, Deepak Voora, Thomas L. Ortel, Tariq Ali Ahmad, Edwin G. Bovill, Redford B. Williams, Cynthia M. Kuhn, Diana A. Gorog, Stefan James and Jeanne M. Corrao and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Richard C. Becker

35 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard C. Becker United States 15 449 196 160 88 66 35 681
Friederike K. Keating United States 13 365 0.8× 180 0.9× 75 0.5× 69 0.8× 41 0.6× 29 567
Helmut Schinzel Germany 11 308 0.7× 157 0.8× 171 1.1× 106 1.2× 82 1.2× 33 660
J.J.C. Jonker Netherlands 12 473 1.1× 156 0.8× 309 1.9× 56 0.6× 52 0.8× 22 666
Robert J. Anders United States 16 905 2.0× 431 2.2× 152 0.9× 170 1.9× 70 1.1× 26 1.2k
S. Mueller Germany 14 466 1.0× 72 0.4× 144 0.9× 48 0.5× 132 2.0× 49 936
Christine Gaud France 8 284 0.6× 148 0.8× 111 0.7× 23 0.3× 64 1.0× 10 497
Wu‐Tao Zeng China 11 310 0.7× 79 0.4× 140 0.9× 34 0.4× 91 1.4× 18 590
S. Gærtner France 13 147 0.3× 190 1.0× 97 0.6× 30 0.3× 36 0.5× 34 609
Chowdhury Ahsan United States 11 264 0.6× 165 0.8× 41 0.3× 69 0.8× 52 0.8× 44 524
Jindřich Špinar Czechia 12 616 1.4× 141 0.7× 94 0.6× 20 0.2× 86 1.3× 127 834

Countries citing papers authored by Richard C. Becker

Since Specialization
Citations

This map shows the geographic impact of Richard C. Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Becker more than expected).

Fields of papers citing papers by Richard C. Becker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard C. Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Becker. The network helps show where Richard C. Becker may publish in the future.

Co-authorship network of co-authors of Richard C. Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Richard C. Becker. A scholar is included among the top collaborators of Richard C. Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard C. Becker. Richard C. Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhatia, Harpreet, Richard C. Becker, Gregor Leibundgut, et al.. (2023). Lipoprotein(a), platelet function and cardiovascular disease. Nature Reviews Cardiology. 21(5). 299–311. 36 indexed citations
2.
Gorog, Diana A. & Richard C. Becker. (2020). Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement. Journal of Thrombosis and Thrombolysis. 51(1). 1–11. 17 indexed citations
3.
Becker, Richard C. & Tarek Helmy. (2015). Are at Least 12 Months of Dual Antiplatelet Therapy Needed for All Patients With Drug-Eluting Stents?. Circulation. 131(22). 2010–2019. 4 indexed citations
4.
Becker, Richard C., et al.. (2015). Aspirin dosing in cardiovascular disease prevention and management: an update. Journal of Thrombosis and Thrombolysis. 40(4). 499–511. 7 indexed citations
5.
Kang, Hyun‐Jae, Robert M. Clare, Claes Held, et al.. (2015). Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. American Heart Journal. 169(6). 899–905.e1. 80 indexed citations
6.
Åkerblom, Axel, Stefan James, H. A. Katus, et al.. (2014). Efficacy and safety of ticagrelor in patients with acute coronary syndrome and heart failure : insights from the platelet inhibition and patient outcomes (PLATO) trial. European Heart Journal. 35. 202–203. 1 indexed citations
7.
Kang, Hyun‐Jae, Robert M. Clare, Runlin Gao, et al.. (2013). Abstract 17001: Net Clinical Benefits of Ticagrelor Compared With Clopidogrel in Asian Acute Coronary Syndrome Patients: A Plato Sub-Study. Circulation. 128. 2 indexed citations
8.
Kang, Hyun‐Jae, Robert M. Clare, Runlin Gao, et al.. (2013). Net Clinical Benefits of Ticagrelor Compared With Clopidogrel in Asian Acute Coronary Syndrome Patients : A Plato Sub-Study. Circulation. 128(22). 2 indexed citations
9.
Jiang, Wei, Zainab Samad, Stephen Boyle, et al.. (2013). Prevalence and Clinical Characteristics of Mental Stress–Induced Myocardial Ischemia in Patients With Coronary Heart Disease. Journal of the American College of Cardiology. 61(7). 714–722. 68 indexed citations
10.
Mentz, Robert J. & Richard C. Becker. (2013). Funding opportunities for clinical investigators in the early stages of career development in cardiovascular research. Journal of Thrombosis and Thrombolysis. 36(4). 527–532. 2 indexed citations
11.
Wallentin, Lars, Stefan James, Evangelos Giannitsis, et al.. (2012). Abstract 15929: Outcomes with Ticagrelor Versus Clopidogrel in Relation to High Sensitivity Troponin-T in Non-ST-Elevation Acute Coronary Syndrome Patients Managed with Early Invasive or Non-Invasive Treatment - A Substudy from the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial. Circulation. 126. 3 indexed citations
12.
Leonardi, Sergio & Richard C. Becker. (2012). PAR-1 Inhibitors: A Novel Class of Antiplatelet Agents for the Treatment of Patients with Atherothrombosis. Handbook of experimental pharmacology. 239–260. 7 indexed citations
13.
Becker, Richard C., Francesco Dentali, Cynthia M. Kuhn, et al.. (2012). Hyperreactive platelet phenotypes: Relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. Thrombosis and Haemostasis. 109(1). 34–38. 29 indexed citations
14.
Wang, Tracy Y., Dominick J. Angiolillo, Mary Cushman, et al.. (2012). Platelet Biology and Response to Antiplatelet Therapy in Women. Journal of the American College of Cardiology. 59(10). 891–900. 55 indexed citations
15.
James, Stefan, Robert F. Storey, Cheryl Bushnell, et al.. (2011). Abstract 15029: Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndromes and History of Stroke or Transient Ischemic Accident: Results from the Platelet Inhibition and Patient Outcomes Trial. Circulation. 124. 1 indexed citations
16.
17.
Becker, Richard C. & Susan S. Smyth. (2009). The evolution of platelet-directed pharmacotherapy. Journal of Thrombosis and Haemostasis. 7. 266–271. 2 indexed citations
18.
Smyth, Susan S., Dougald M. Monroe, Waldemar E. Wysokiński, et al.. (2007). Platelet activation and its patient-specific consequences. Thrombosis Research. 122(4). 435–441. 6 indexed citations
19.
Becker, Richard C.. (2006). Biosignatures in thrombotic disorders. Journal of Thrombosis and Thrombolysis. 22(2). 157–158. 2 indexed citations
20.
Becker, Richard C., Christopher P. Cannon, Russell P. Tracy, et al.. (1996). Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardial infarction. American Heart Journal. 131(3). 421–433. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Friederike K. Keating Breakdown of academic impact, for papers by Helmut Schinzel Breakdown of academic impact, for papers by J.J.C. Jonker Breakdown of academic impact, for papers by Robert J. Anders Breakdown of academic impact, for papers by S. Mueller Breakdown of academic impact, for papers by Christine Gaud Breakdown of academic impact, for papers by Wu‐Tao Zeng Breakdown of academic impact, for papers by S. Gærtner Breakdown of academic impact, for papers by Chowdhury Ahsan Breakdown of academic impact, for papers by Jindřich Špinar
Rankless by CCL
2026